{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:55Z","timestamp":1791309895979,"version":"4.3.1"},"reference-count":79,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Zhejiang Province.","award":["LY12H03003"],"award-info":[{"award-number":["LY12H03003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis B virus (HBV) infection has persisted as a major public health problem due to the lack of an effective treatment for those chronically infected. Therapeutic vaccination holds promise, and targeting HBV polymerase is pivotal for viral eradication. In this research, a computational approach was employed to predict suitable HBV polymerase targeting multi-peptides for vaccine candidate selection. We then performed in-depth computational analysis to evaluate the predicted epitopes\u2019 immunogenicity, conservation, population coverage, and toxicity. Lastly, molecular docking and MHC-peptide complex stabilization assay were utilized to determine the binding energy and affinity of epitopes to the HLA-A0201 molecule. Criteria-based analysis provided four predicted epitopes, RVTGGVFLV, VSIPWTHKV, YMDDVVLGA and HLYSHPIIL. Assay results indicated the lowest binding energy and high affinity to the HLA-A0201 molecule for epitopes VSIPWTHKV and YMDDVVLGA and epitopes RVTGGVFLV and VSIPWTHKV, respectively. Regions 307 to 320 and 377 to 387 were considered to have the highest probability to be involved in B cell epitopes. The T cell and B cell epitopes identified in this study are promising targets for an epitope-focused, peptide-based HBV vaccine, and provide insight into HBV-induced immune response.<\/jats:p>","DOI":"10.3390\/v9050112","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T11:42:11Z","timestamp":1494934931000},"page":"112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein"],"prefix":"10.3390","volume":"9","author":[{"given":"Juzeng","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wenzhou People\u2019s Hospital, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators (2015). Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385, 117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Chan","year":"2014","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs: Progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: State-of-the-art and unresolved questions\u2014Report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000360938","article-title":"Host factor-targeted hepatitis B virus therapies","volume":"57","author":"Gehring","year":"2014","journal-title":"Intervirology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/v2071394","article-title":"Innate antiviral immune responses to hepatitis B virus","volume":"2","author":"Lucifora","year":"2010","journal-title":"Viruses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2010.12.031","article-title":"Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges","volume":"54","author":"Michel","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.20071949","article-title":"Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection","volume":"205","author":"Ha","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2012.12.074","article-title":"A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice","volume":"31","author":"Buchmann","year":"2013","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2007.09.072","article-title":"Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg\/AS02 candidate vaccine and lamivudine","volume":"25","author":"Vandepapeliere","year":"2007","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2893.2010.01320.x","article-title":"Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B","volume":"18","author":"Akbar","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2015.12.060","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/fvl.14.113","article-title":"Unveiling the roles of HBV polymerase for new antiviral strategies","volume":"10","author":"Clark","year":"2015","journal-title":"Future Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: Mechanism of action and resistance","volume":"8","author":"Alvarez","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: Implications on vaccine development","volume":"53","year":"2015","journal-title":"J. Biomed. Inform."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311","volume":"36","author":"Lundegaard","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Peters, B., and Sette, A. (2005). Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinform., 6.","DOI":"10.1186\/1471-2105-6-132"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jim.2013.10.003","article-title":"MHC-NP: Predicting peptides naturally processed by the MHC","volume":"400\u2013401","author":"Giguere","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: Pan-specific MHC class I pathway epitope predictions","volume":"62","author":"Stranzl","year":"2010","journal-title":"Immunogenetics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00251-004-0709-7","article-title":"Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles","volume":"56","author":"Reche","year":"2004","journal-title":"Immunogenetics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-60327-118-9_13","article-title":"Prediction of peptide-MHC binding using profiles","volume":"409","author":"Reche","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0198-8859(02)00432-9","article-title":"Prediction of MHC class I binding peptides using profile motifs","volume":"63","author":"Reche","year":"2002","journal-title":"Hum. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nielsen, M., and Andreatta, M. (2016). NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Med., 8.","DOI":"10.1186\/s13073-016-0288-x"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Calis, J.J., Maybeno, M., Greenbaum, J.A., Weiskopf, D., de Silva, A.D., Sette, A., Kesmir, C., and Peters, B. (2013). Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput. Biol., 9.","DOI":"10.1371\/journal.pcbi.1003266"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bui, H.H., Sidney, J., Li, W., Fusseder, N., and Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-361"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., and Raghava, G.P. (2013). Open SOURCE DRUG DISCOVERY CONSORTIUM. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073957"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: Application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinform."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2015.04.026","article-title":"Immigration and viral hepatitis","volume":"63","author":"Sharma","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bui, H.H., Sidney, J., Dinh, K., Southwood, S., Newman, M.J., and Sette, A. (2006). Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform., 7.","DOI":"10.1186\/1471-2105-7-153"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Shen","year":"2014","journal-title":"J. Chem. Theory Comput."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"W288","DOI":"10.1093\/nar\/gks419","article-title":"PEP-FOLD: An updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides","volume":"40","author":"Thevenet","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1002\/anie.201406295","article-title":"Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides","volume":"53","author":"Choo","year":"2014","journal-title":"Angew. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3892\/ijo.2013.1834","article-title":"Two novel squamous cell carcinoma antigen-derived HLA-A*0201-binding peptides induce in vitro and in vivo CD8+ cytotoxic T lymphocyte responses","volume":"42","author":"Duan","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ponomarenko, J.V., and Bourne, P.E. (2007). Antibody-protein interactions: Benchmark datasets and prediction tools evaluation. BMC Struct. Biol., 7.","DOI":"10.1186\/1472-6807-7-64"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1110\/ps.062405906","article-title":"Prediction of residues in discontinuous B-cell epitopes using protein 3D structures","volume":"15","author":"Nielsen","year":"2006","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"key":"ref_45","first-page":"45","article-title":"Prediction of the secondary structure of proteins from their amino acid sequence","volume":"47","author":"Chow","year":"1978","journal-title":"Adv. Enzymol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","article-title":"Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide","volume":"55","author":"Emini","year":"1985","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF01195768","article-title":"Prediction of chain flexibility in proteins","volume":"72","author":"Karplus","year":"1985","journal-title":"Naturwissenschaften"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/bi00367a013","article-title":"New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites","volume":"25","author":"Parker","year":"1986","journal-title":"Biochemistry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/sji.12302","article-title":"Epitope-based peptide vaccine design and target site depiction against Ebola viruses: An immunoinformatics study","volume":"82","author":"Khan","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.13694","article-title":"Review article: Novel therapies for hepatitis B virus cure\u2014Advances and perspectives","volume":"44","author":"Lin","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4155\/fmc.15.19","article-title":"Recent advance of the hepatitis B virus inhibitors: A medicinal chemistry overview","volume":"7","author":"Jia","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.molimm.2014.08.003","article-title":"In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors","volume":"63","author":"Lobaina","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12967-014-0361-4","article-title":"An autophagosome-based therapeutic vaccine for HBV infection: A preclinical evaluation","volume":"12","author":"Xue","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26654","article-title":"Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection","volume":"59","author":"Lv","year":"2014","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2010.04.023","article-title":"Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice","volume":"28","author":"Qing","year":"2010","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clim.2010.07.002","article-title":"Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: Implication of its potential use as a therapeutic vaccine","volume":"137","author":"Zhou","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/intimm\/dxh305","article-title":"A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice","volume":"17","author":"Li","year":"2005","journal-title":"Int. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/liv.12530","article-title":"Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice","volume":"35","author":"Yoon","year":"2015","journal-title":"Liver Int."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Cavenaugh, J.S., Awi, D., Mendy, M., Hill, A.V., Whittle, H., and McConkey, S.J. (2011). Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0014626"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0684.2006.00152.x","article-title":"Attempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral load","volume":"35","author":"Shata","year":"2006","journal-title":"J. Med. Primatol."},{"key":"ref_62","first-page":"467","article-title":"Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics","volume":"18","author":"Dhanda","year":"2017","journal-title":"Brief. Bioinform."},{"key":"ref_63","first-page":"21","article-title":"Machine learning methods for predicting HLA-peptide binding activity","volume":"9","author":"Luo","year":"2015","journal-title":"Bioinform. Biol. Insights"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1631\/jzus.B1200299","article-title":"Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data","volume":"14","author":"Lu","year":"2013","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","article-title":"Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors","volume":"171","author":"Peters","year":"2003","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/iji.12214","article-title":"Computer-aided design of T-cell epitope-based vaccines: Addressing population coverage","volume":"42","author":"Oyarzun","year":"2015","journal-title":"Int. J. Immunogenet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coviro.2015.03.013","article-title":"Computational tools for epitope vaccine design and evaluation","volume":"11","author":"He","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kringelum, J.V., Lundegaard, C., Lund, O., and Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Comput. Biol., 8.","DOI":"10.1371\/journal.pcbi.1002829"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkp417","article-title":"SEPPA: A computational server for spatial epitope prediction of protein antigens","volume":"37","author":"Sun","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/iji.12260","article-title":"Prediction and preliminary screening of HLA-A*0201-restricted epitope peptides of human GPC3","volume":"43","author":"Hu","year":"2016","journal-title":"Int. J. Immunogen."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00726-011-0966-3","article-title":"Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer","volume":"42","author":"Liu","year":"2012","journal-title":"Amino Acids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3892\/mmr.2015.3673","article-title":"Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8","volume":"12","author":"Tang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cas.12308","article-title":"In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies","volume":"105","author":"Tang","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.vaccine.2015.10.108","article-title":"Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes","volume":"34","author":"Xu","year":"2016","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2011.06.009","article-title":"Identification of novel T cell epitopes from efflux pumps of Mycobacterium tuberculosis","volume":"140","author":"Zhu","year":"2011","journal-title":"Immunol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jmv.21736","article-title":"Identification of a dengue virus-specific HLA-A*0201-restricted CD8+ T cell epitope","volume":"82","author":"Wen","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2015.11.042","article-title":"Prediction and identification of novel IBV S1 protein derived CTL epitopes in chicken","volume":"34","author":"Tan","year":"2016","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: Progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.09.050","article-title":"5\u2032-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","volume":"721","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/5\/112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:36:01Z","timestamp":1760207761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/5\/112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5]]}},"alternative-id":["v9050112"],"URL":"https:\/\/doi.org\/10.3390\/v9050112","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]}}}